DefEYE, Inc.
PrivateLast Round
Seed
Oct 22, 2025
Est. Valuation
$31M
Total Funding Raised
$12M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
DefEYE, Inc. is a biotechnology company that develops and commercializes decellularized biologic solutions, including amniotic barrier membranes, for the management of ocular surface diseases and surgical recovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DefEYE, Inc. Comparables
Compare DefEYE, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merakris Therapeutics | 87% | |
| Oculus Biologics | 86% | |
| Skye Biologics Holdings | 85% |
DefEYE, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 22, 2025 |
DefEYE, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ExSight Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Jul 30, 2026
Grew 45% QoQ, from 11 to 16 employees.
DefEYE, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DefEYE, Inc.'s valuation, stock price, and market status.
Is DefEYE, Inc. a public or private company?
DefEYE, Inc. is a private company.
What is the current stock price of DefEYE, Inc.?
DefEYE, Inc. is a private company with no public stock price. Caplight tracks DefEYE, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is DefEYE, Inc. worth (valuation)?
DefEYE, Inc.'s valuation is estimated at $31.0M based on funding round data.
Can I buy DefEYE, Inc. stock?
DefEYE, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DefEYE, Inc.'s last funding round?
DefEYE, Inc.'s most recent funding round was Seed on October 22, 2025.
Who are the main investors in DefEYE, Inc.?
Key investors in DefEYE, Inc. include ExSight Ventures.
Will DefEYE, Inc. IPO soon?
No public IPO plans have been announced for DefEYE, Inc..
How can I track DefEYE, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DefEYE, Inc.'s secondary market activity and sign up for updates.